Aims Inappropriate therapy delivered by implantable cardioverter defibrillators (ICDs)
remains a challenge. The OPERA registry measured the times to, and studied the …

Importance Clinical trials of prophylactic implantable cardioverter-defibrillators (ICDs) have
included a minority of patients with a left ventricular ejection fraction (LVEF) between 30 …

Aims: We reviewed outcomes in our primary prevention implantable cardioverter defibrillator
(ICD) population according to whether the device was programmed with a single ventricular …

Background: Inappropriate implantable cardioverter defibrillator (ICD) shocks have been
linked to a worse clinical outcome due to direct myocardial injury. Hypothesis: The …

Background—ICD therapy is established therapy for secondary prevention after aborted
sudden death or ventricular tachycardia. Long-term data on the incidence of appropriate and …

The use of implantable cardioverter-defibrillators (ICDs) significantly reduces the risk of
mortality in patients with heart failure with reduced ejection fraction (HFrEF). Current …

Background Inappropriate implantable cardioverter‐defibrillator programming can be
detrimental. Whether trials/recommendations informing best implantable cardioverter …

Since the widespread implementation of implantable cardioverter-defibrillators (ICDs), their
effectiveness in various situations has become well-established. However, despite many …

Aims Use of implantable cardioverter‐defibrillators (ICD) for primary prevention of sudden
cardiac death (SCD) in heart failure with reduced ejection fraction (HFrEF) is limited. We …

Objectives: This study investigated the benefit of an implantable cardioverter-defibrillator
(ICD) generator replacement in patients who did not have an ongoing theoretical indication …